These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12114431)

  • 1. Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curability.
    Peghini PL; Iwamoto M; Raffeld M; Chen YJ; Goebel SU; Serrano J; Jensen RT
    Clin Cancer Res; 2002 Jul; 8(7):2273-85. PubMed ID: 12114431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases.
    Furukawa M; Raffeld M; Mateo C; Sakamoto A; Moody TW; Ito T; Venzon DJ; Serrano J; Jensen RT
    Clin Cancer Res; 2005 May; 11(9):3233-42. PubMed ID: 15867218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
    Tolgay Ocal I; Dolled-Filhart M; D'Aquila TG; Camp RL; Rimm DL
    Cancer; 2003 Apr; 97(8):1841-8. PubMed ID: 12673709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
    Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
    Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness.
    Goebel SU; Iwamoto M; Raffeld M; Gibril F; Hou W; Serrano J; Jensen RT
    Cancer Res; 2002 Jul; 62(13):3702-10. PubMed ID: 12097278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.
    Takeuchi H; Bilchik A; Saha S; Turner R; Wiese D; Tanaka M; Kuo C; Wang HJ; Hoon DS
    Clin Cancer Res; 2003 Apr; 9(4):1480-8. PubMed ID: 12684423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of hepatocyte growth factor receptor and epidermal growth factor receptor of human hepatocytes can be maintained in a (3D) collagen sandwich culture system.
    Engl T; Boost KA; Leckel K; Beecken WD; Jonas D; Oppermann E; Auth MK; Schaudt A; Bechstein WO; Blaheta RA
    Toxicol In Vitro; 2004 Aug; 18(4):527-32. PubMed ID: 15130610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
    Tuck AB; Park M; Sterns EE; Boag A; Elliott BE
    Am J Pathol; 1996 Jan; 148(1):225-32. PubMed ID: 8546209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
    Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth.
    Chen YJ; Vortmeyer A; Zhuang Z; Gibril F; Jensen RT
    Cancer; 2004 Apr; 100(7):1379-87. PubMed ID: 15042671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of gastrinomas by immunohistochemistry and in situ hybridization histochemistry.
    Perkins PL; McLeod MK; Jin L; Fukuuchi A; Cho KJ; Thompson NW; Lloyd RV
    Diagn Mol Pathol; 1992 Sep; 1(3):155-64. PubMed ID: 1285276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance.
    Chen YJ; Vortmeyer A; Zhuang Z; Huang S; Jensen RT
    Cancer Res; 2003 Feb; 63(4):817-23. PubMed ID: 12591732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
    Theodoropoulou M; Arzberger T; Gruebler Y; Jaffrain-Rea ML; Schlegel J; Schaaf L; Petrangeli E; Losa M; Stalla GK; Pagotto U
    J Endocrinol; 2004 Nov; 183(2):385-94. PubMed ID: 15531726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.
    Yeh TS; Tseng JH; Liu NJ; Chen TC; Jan YY; Chen MF
    Arch Surg; 2005 Dec; 140(12):1184-90. PubMed ID: 16365240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies.
    Weinberger PM; Yu Z; Kowalski D; Joe J; Manger P; Psyrri A; Sasaki CT
    Arch Otolaryngol Head Neck Surg; 2005 Aug; 131(8):707-11. PubMed ID: 16103303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors.
    Moroni M; Veronese S; Schiavo R; Carminati O; Sorensen BS; Gambacorta M; Siena S
    Clin Cancer Res; 2001 Sep; 7(9):2770-5. PubMed ID: 11555591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases.
    Kuramochi H; Hayashi K; Nakajima G; Kamikozuru H; Yamamoto M; Danenberg KD; Danenberg PV
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):825-31. PubMed ID: 19701635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.